Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.

@article{Boland1999ContinuousSI,
  title={Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.},
  author={Elizabeth A Boland and Margaret Grey and August {\"O}sterle and Lynn Fredrickson and William V Tamborlane},
  journal={Diabetes care},
  year={1999},
  volume={22 11},
  pages={1779-84}
}
OBJECTIVE Recommendations from the Diabetes Control and Complications Trial (DCCT) indicate that adolescents with type 1 diabetes should be treated with intensive therapy involving multiple daily injections (MDI) of insulin or insulin pump therapy (continuous subcutaneous insulin infusion [CSII] to help obtain better metabolic control and prevent later complications. Interest has thus focused on insulin pump therapy to help adolescents meet this challenge. The purpose of this study was to… CONTINUE READING